Great Point Partners LLC Karuna Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $409 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$161.01 - $317.85 $4.87 Million - $9.61 Million
-30,250 Reduced 50.0%
30,250 $9.57 Million
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $9.96 Million - $13.2 Million
60,500 New
60,500 $10.2 Million
Q2 2022

Aug 15, 2022
BUY
$93.97 - $143.33 $14 Million - $21.4 Million
149,000 New
149,000 $18.9 Million

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email